M&G Investment Management LTD Esperion Therapeutics, Inc. Transaction History

M&G Investment Management LTD

  • $28.2 Trillion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022
SELL
$4.81 - $11.92 $102,323 - $253,574
-21,273 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$11.34 - $21.37 $167,639 - $315,912
-14,783 Reduced 41.0%
21,273 $256,000
Q2 2021

Aug 16, 2021
BUY
$19.4 - $28.71 $699,486 - $1.04 Million
36,056 New
36,056 $757,000

Others Institutions Holding ESPR

# of Institutions
214
Shares Held
129M
Call Options Held
1.78M
Put Options Held
1.27M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $124M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email